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Background: Gastrointestinal bleeding due to duodenal metastasis from renal cell carcinoma is extremely rare.
Several previous reports have shown that embolic therapy or pancreatoduodenectomy (radical surgical resection)
could be effective in controlling this type of clinical complication. Management is entirely dependent on the
general condition and concurrent metastases at other sites. Optimizing the therapeutic strategies thus deserves
further discussion and exploration.
Methods: In this report, we describe a patient with severe co-morbidities who underwent successful palliative
wedge resection of duodenum and direct duodenal wall defect repair without reconstruction of
duodeno-jejunostomy for acute upper digestive tract hemorrhage caused by duodenal metastasis from renal clear
cell carcinoma.
Results: The patient recovered uneventfully and did not experience rebleeding and frequent vomiting after
surgery. Since then (1.5 years) he has had no evidence of rebleeding.
Conclusions: Gastrointestinal bleeding due to duodenal metastasis of RCC may benefit from emergent resection
even in the presence of severe co-morbidities, and for palliative treatment.
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Renal cell carcinoma (RCC) accounts for 3% of all adult
malignancies, and is the third most frequent urologic
malignancy after prostate and bladder cancer [1]. Add-
itionally, nearly 25% to 50% will develop metastatic disease
metachronously after surgical treatment of the primary
renal mass [2]. While the most common sites of metastasis
are the lung, bone, liver, adrenal, and brain, some unusual
sites have also been reported including the iris, thyroid,
breast, urinary bladder, epididymis, small bowel, pancreas,
spleen, gallbladder, and ampulla [3,4]. Acute upper gastro-
intestinal hemorrhage due to duodenal metastasis from
RCC is a rare event. To the best of our knowledge, there
have been a few reports in which embolic therapy or pan-
creatoduodenectomy have been employed to stop bleeding
from RCC duodenal metastasis. Both methods are proved* Correspondence: Liangp303@medmail.com.cn
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reproduction in any medium, provided the orto be useful in controlling upper gastrointestinal bleeding
from this cause [2,5]. Embolization is a less invasive sur-
gery but the RCC metastasis may re-bleed after treatment.
On the other hand pancreatoduodenectomy offers control
of bleeding and cure of duodenal metastasis but in these
patients morbidities from the procedure may be excessive.
In other words, such surgical therapy could not only stop
bleeding but also remove the duodenal metastatic tumor,
in spite of high risk of morbidity especially for those
patients suffering from cachexia to go through the surgical
procedure. Here, we present a case of successful manage-
ment of duodenal bleeding caused by metastasis from
RCC by a wedge resection of duodenum with an excellent
long-term outcome.Methods
Preoperative diagnostics and medical history
A 56-year-old man was referred to us with a diagnosis of
presumed duodenal carcinoma.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Gastroscopy showing a mass in the descending
portion of the duodenum with mucosal ulcerations and focal
hemorrhage. The whole lumen of the duodenum was occupied by
the tumor, and the duodenal papilla cannot be visualized.
Figure 2 Upper GI meal barium showing a filling-defect in the
descending and the horizontal portion of the duodenum.
The mucous membrane was not smooth, and there was limited
dilatation.
Figure 3 Abdominal computed tomography showed a 2.0 cm
enhancing mass in the pancreatic tail. According to CT arterial
phase, the pancreatic mass revealed enhancing lesions.
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for renal clear cell carcinoma (pT2, pV0, pN0: stage II).
The postoperative course was uneventful and no adju-
vant therapy was given. During the 5-year follow-up,
fecal occult blood test had been carried out as a routine
test. No signs of tumor recurrence were detected during
the follow-up with annual abdominal ultrasonography,
and the physical examination was unremarkable.
The patient was admitted by the department of gas-
troenterology. The main complaints were generalized
fatigue, continuous melena, and frequent vomiting for
20 days. These symptoms were not relieved by using
medications and supportive care (like fluids, parenteral
nutrition, and blood transfusion). For further treatment,
after 20 days admission, the patient was transferred to the
department of hepatobiliary surgery. Peripheral blood cell
counts demonstrated severe anemia and a hemoglobin
level of (54 g/L). Blood analyses revealed hypoproteinemia
(44 g/L) with hypoalbuminemia (25 g/L). Other laboratory
examinations such as blood chemistry and serum tumor
markers were normal. Gastroscopy showed a mass in the
descending part of the duodenum with mucosal ulcera-
tions and focal hemorrhage. The whole lumen of the duo-
denum was occupied by the mass, and the duodenal
papilla could not be visualized (Figure 1). A duodenal
biopsy was performed and histopathology diagnosis sug-
gested adenocarcinoma of the duodenum. An upper GI
series showed a filling-defect in the same area (Figure 2),
and an abdominal computed tomography (CT) confirmed
the presence of a 2.5-cm filling-defect. Another lesion
2.0 cm in diameter was detected in the pancreatic tail(Figure 3). Preoperative clinical diagnostic evaluation
resulted in the diagnosis of a massive gastrointestinal
bleeding, duodenal carcinoma with incomplete duodenal
obstruction, pancreatic tail carcinoma, severe anemia,
hypoalbuminemia, renal cell carcinoma status post right
nephrectomy.
Surgical therapy
An exploratory laparotomy was carried out through a
median laparotomy incision. A standard Kocher maneu-
ver opening the gastrocolic ligament was performed to
assess the duodenum and the extent of lesion. The lat-
eral wall of the descending part of duodenum was longi-
tudinally opened to visualize the ampulla of Vater and
Figure 4 Tumor invasion of the descending duodenum with
mucosal ulcerations and focal hemorrhage. The ampulla of Vater
was not affected, but part of the duodenum was tightly adherent to
the surrounding tissue, including the inferior vena cava and
retroperitoneal space.
Figure 5 Gross appearance of the resected tumor.
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identified that invaded the descending part of duodenum
wall but not the ampulla of Vater. Part of the lesion was
tightly adhered to the surrounding tissue, including
part of the inferior vena cava and retroperitoneal space
(Figure 4). After completely separating it from the inferior
vena cava and retroperitoneal space, the lesion with part
of duodenum was finally removed from duodenum to
complete the resection. A full-thickness wedge resection
and direct duodenal wall defect repair were performed,
but without reconstruction of duodeno-jejunostomy. The
intraoperative frozen sections confirmed the lesion of
pancreatic tail and duodenum metastasis from RCC.
According to the results of laparotomy and preoperative
CT, if the lesion on the pancreatic tail was resected, the
spleen would also have to be removed. In general, if
anemia and hypoproteinemia had been effectively cor-
rected, resection of duodenal and pancreatic tail, or even
spleen resection, would have been feasible. Considering
the patient’s poor general condition (severe anemia,
hypoalbuminemia), tumor location and involvement, a
local resection via duodenostomy was performed and the
lesion in the pancreatic tail was left untreated for saving
the patient’s life as the first priority.
Results and discussion
Postoperative clinical course and histopathology
Pathologic findings revealed a 4.3-cm mass in the duo-
denal that appeared to be a clear cell carcinoma of renal
origin (Figure 5). Immunohistochemistry of the mass
revealed strong and diffuse expression of cytokeratin 18
and RCC in tumor clear cells (Figure 6A, 6B). Immunos-
taining for CD117, vimentin, and EGFR were uniformly
negative in tumor cells. Upon microscopic examinationof hematoxylin and eosin (HE)-stained tissue sections,
the duodenal mass was found to be populated by poly-
gonal cells with clear cytoplasm and relatively uniform
nuclei, some of which exhibited prominent nucleoli
(Figure 6C). Based on the above information, a diagno-
sis of duodenal and pancreatic tail metastasis by renal
clear cell carcinoma was made. The patient recovered
uneventfully and did not experience rebleeding and fre-
quent vomiting after surgery. Since then (1.5 years) he
has had no evidence of rebleeding.
Discussion
RCC metastasis to the duodenum is a rare event,
accounting for 7.1% of all small bowel metastases [6,7].
Duodenal metastasis from RCC may present with abdom-
inal pain, nausea, weight loss, jaundice, anemia, gastro-
intestinal bleeding, duodenal obstruction, perforation
and duodenal intussusceptions [8]. It can occur at any
time after nephrectomy [9], and is indistinguishable from
other gastrointestinal diseases. If there are specific muco-
sal changes in the duodenal lumen, the diagnosis can be
made by gastroscopy. The diagnosis should be consid-
ered in any patient with upper gastrointestinal bleeding
or obstructive symptoms and with right-sided renal
tumor or radical nephrectomy in the past [10] (even if
metastasis of renal cell carcinoma cannot be definitely
diagnosed in routine duodenal biopsy at gastroscopy).
There have been several reports on the use of stannio-
calcin 2 (STC2) as a marker for the diagnosis of duodenal
metastasis from RCC [9]. Results from these studies indi-
cate that STC2 may indeed be useful in determining the
postoperative risk stratification of those patients.
Up to now there have been several similar cases re-
porting acute upper gastrointestinal hemorrhage due to
duodenal metastasis from RCC. Currently management
Figure 6 (A) Immunohistochemical staining by renal cell carcinoma (RCC) (original magnification, ×400). (B) Immunohistochemical
staining by Cytokeratin 18 (CK18) (original magnification, ×400). (C) Hematoxylin and eosin (HE)-staining showing polygonal cells with clear
cytoplasm and relatively uniform nuclei, some of them exhibiting prominent nucleoli (original magnification, ×400).
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current metastases at other sites [8]. Although immediate
life-saving treatment requires emergency arteriography
and arterial embolization [5], complications including
rebleeding, gastrointestinal ischemia, and non-target em-
bolization are relatively encountered [8]. Moreover, the
duodenal obstruction is not solved by using embolization
at all. Additionally, the patient was admitted by the de-
partment of gastroenterology for 20 days. For the reason
of incomplete duodenal obstruction, the patient could
not eat food, even in a liquid form. Anemia, hypoprotei-
nemia, and frequent vomiting were not relieved by using
medications and supportive care (like fluids, parenteral
nutrition, and blood transfusion). The family of the pa-
tient could not continue to bear the economic burden
and even prepared to abandon the treatment. According
to the patient’s clinical conditions (gastrointestinal bleed-
ing with incomplete duodenal obstruction) and economic
situation, emergent surgical intervention to stop bleeding
and relieve obstruction of the duodenum is the preferred
choice. In terms of the surgical treatment of duodenal
carcinoma, the most conventional and effective surgical
method is pancreatoduodenectomy. Surgical resection
of solitary metastatic renal cell carcinoma has resulted
in 5-year survival rates from 35% to 50%, and a 5-yeardisease-free survival rate of 5% to 23% [11]. However, be-
cause of the complications and surgical massive trauma
associated with this procedure and the poor condition of
the patient, a less aggressive and palliative treatment was
selected without treating the pancreatic tail, in order
to minimize the complications and improve the quality
of life. Therefore, a segmental, palliative full-thickness
wedge resection of duodenum was emergent undertaken.
This procedure can be performed safely if basic princi-
ples are followed:
1) A Kocher maneuver is performed to assess the
anatomic relationship between the lesion and the bile
duct and head of the pancreas. The ampulla of Vater
is carefully identified and preserved during the
resection process.
2) The lesion is carefully dissected away from the
inferior vena cava and retroperitoneal structures.
Vascular anastomotic devices and an adequate supply
of blood should be present.
3) Clear surgical margins of 1 or 2 cm are obtained [12].
4) A longitudinal incision and transverse suturing of
the duodenum is performed to prevent stricture of
the duodenum.
5) A patent distal jejunum is present.
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In conclusion, gastrointestinal bleeding due to duodenal
metastasis of RCC may benefit from emergent resection
even in the presence of severe co-morbidities (severe
anemia, hypoalbuminemia, and incomplete duodenal
obstruction), and for palliative treatment.
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